R.M. Davis Inc’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $301K | Sell |
12,484
-813
| -6% | -$21.3K | ﹤0.01% | 244 |
|
|
2026
Q1 | $373K | Buy |
13,297
+1,493
| +13% | +$39.7K | 0.01% | 216 |
|
|
2025
Q4 | $294K | Sell |
11,804
-1,083
| -8% | -$27.3K | 0.01% | 236 |
|
|
2025
Q3 | $328K | Sell |
12,887
-655
| -5% | -$16.2K | 0.01% | 226 |
|
|
2025
Q2 | $328K | Sell |
13,542
-9,747
| -42% | -$227K | 0.01% | 227 |
|
|
2025
Q1 | $590K | Sell |
23,289
-1,034
| -4% | -$27.1K | 0.01% | 186 |
|
|
2024
Q4 | $645K | Sell |
24,323
-28,734
| -54% | -$779K | 0.01% | 177 |
|
|
2024
Q3 | $1.54M | Sell |
53,057
-6,977
| -12% | -$204K | 0.03% | 130 |
|
|
2024
Q2 | $1.68M | Sell |
60,034
-12,497
| -17% | -$344K | 0.03% | 123 |
|
|
2024
Q1 | $2.01M | Sell |
72,531
-31,628
| -30% | -$878K | 0.04% | 117 |
|
|
2023
Q4 | $3M | Sell |
104,159
-174,944
| -63% | -$5.29M | 0.07% | 106 |
|
|
2023
Q3 | $9.26M | Sell |
279,103
-67,829
| -20% | -$2.4M | 0.23% | 91 |
|
|
2023
Q2 | $12.7M | Buy |
346,932
+9,375
| +3% | +$365K | 0.31% | 84 |
|
|
2023
Q1 | $13.8M | Buy |
337,557
+14,509
| +4% | +$627K | 0.35% | 82 |
|
|
2022
Q4 | $16.6M | Buy |
323,048
+18,822
| +6% | +$902K | 0.45% | 73 |
|
|
2022
Q3 | $13.3M | Sell |
304,226
-16,897
| -5% | -$821K | 0.39% | 81 |
|
|
2022
Q2 | $16.8M | Buy |
321,123
+317
| +0.1% | +$16.2K | 0.47% | 74 |
|
|
2022
Q1 | $16.6M | Buy |
320,806
+4,148
| +1% | +$215K | 0.4% | 81 |
|
|
2021
Q4 | $18.7M | Buy |
316,658
+9,290
| +3% | +$460K | 0.42% | 78 |
|
|
2021
Q3 | $13.2M | Buy |
307,368
+7,616
| +3% | +$337K | 0.33% | 87 |
|
|
2021
Q2 | $11.7M | Buy |
299,752
+25,002
| +9% | +$972K | 0.3% | 90 |
|
|
2021
Q1 | $9.95M | Buy |
274,750
+23,250
| +9% | +$826K | 0.27% | 92 |
|
|
2020
Q4 | $9.26M | Buy |
251,500
+28,735
| +13% | +$1.05M | 0.27% | 89 |
|
|
2020
Q3 | $7.76M | Buy |
222,765
+37,952
| +21% | +$1.33M | 0.25% | 89 |
|
|
2020
Q2 | $5.73M | Buy |
184,813
+32,655
| +21% | +$1.11M | 0.2% | 91 |
|
|
2020
Q1 | $4.71M | Buy |
152,158
+28,467
| +23% | +$970K | 0.2% | 90 |
|
|
2019
Q4 | $4.6M | Buy |
123,691
+6,782
| +6% | +$242K | 0.15% | 95 |
|
|
2019
Q3 | $3.98M | Buy |
116,909
+24,958
| +27% | +$908K | 0.14% | 95 |
|
|
2019
Q2 | $3.78M | Buy |
91,951
+33,680
| +58% | +$1.34M | 0.13% | 96 |
|
|
2019
Q1 | $2.35M | Buy |
58,271
+7,490
| +15% | +$300K | 0.09% | 104 |
|
|
2018
Q4 | $2.1M | Sell |
50,781
-1,386
| -3% | -$57.5K | 0.09% | 105 |
|
|
2018
Q3 | $2.18M | Sell |
52,167
-4,375
| -8% | -$168K | 0.08% | 105 |
|
|
2018
Q2 | $1.95M | Sell |
56,542
-6,366
| -10% | -$218K | 0.08% | 106 |
|
|
2018
Q1 | $2.12M | Sell |
62,908
-2,181
| -3% | -$75K | 0.08% | 103 |
|
|
2017
Q4 | $2.24M | Buy |
65,089
+4,732
| +8% | +$161K | 0.09% | 101 |
|
|
2017
Q3 | $2.04M | Buy |
60,357
+7,968
| +15% | +$256K | 0.08% | 104 |
|
|
2017
Q2 | $1.67M | Sell |
52,389
-12,443
| -19% | -$392K | 0.07% | 109 |
|
|
2017
Q1 | $2.1M | Sell |
64,832
-19,159
| -23% | -$604K | 0.1% | 99 |
|
|
2016
Q4 | $2.59M | Sell |
83,991
-1,810
| -2% | -$55.3K | 0.12% | 93 |
|
|
2016
Q3 | $2.76M | Buy |
85,801
+13,926
| +19% | +$466K | 0.13% | 94 |
|
|
2016
Q2 | $2.4M | Buy |
71,875
+2,925
| +4% | +$93.4K | 0.12% | 92 |
|
|
2016
Q1 | $1.94M | Buy |
68,950
+5,718
| +9% | +$163K | 0.1% | 98 |
|
|
2015
Q4 | $1.94M | Sell |
63,232
-2,772
| -4% | -$87.2K | 0.1% | 96 |
|
|
2015
Q3 | $1.97M | Buy |
66,004
+11,462
| +21% | +$368K | 0.11% | 102 |
|
|
2015
Q2 | $1.74M | Sell |
54,542
-1,033
| -2% | -$33.7K | 0.09% | 104 |
|
|
2015
Q1 | $1.83M | Buy |
55,575
+2,961
| +6% | +$94.1K | 0.1% | 99 |
|
|
2014
Q4 | $1.55M | Buy |
52,614
+5,495
| +12% | +$158K | 0.09% | 103 |
|
|
2014
Q3 | $1.32M | Sell |
47,119
-4,416
| -9% | -$124K | 0.08% | 106 |
|
|
2014
Q2 | $1.45M | Sell |
51,535
-7,584
| -13% | -$216K | 0.08% | 101 |
|
|
2014
Q1 | $1.8M | Sell |
59,119
-1,322
| -2% | -$39.4K | 0.11% | 94 |
|
|
2013
Q4 | $1.76M | Sell |
60,441
-385
| -0.6% | -$11.2K | 0.11% | 95 |
|
|
2013
Q3 | $1.66M | Sell |
60,826
-3,124
| -5% | -$85K | 0.11% | 91 |
|
|
2013
Q2 | $1.7M | Buy |
+63,950
| New | +$1.77M | 0.12% | 89 |
|
Other funds holding PFE
R.M. Davis Inc's PFE Position: Q2 2026 in Review
R.M. Davis Inc reduced its Pfizer (PFE) stake by 6.1% in Q2 2026, selling an estimated $21.3K and leaving 12,484 shares worth $301K. The position accounts for ﹤0.01% of the portfolio, ranked #244.
R.M. Davis Inc first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $18.7M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- R.M. Davis Inc held 12,484 shares of Pfizer worth $301K as of Q2 2026.
- R.M. Davis Inc sold 813 Pfizer shares in Q2 2026, an estimated $21.3K.
- Pfizer made up ﹤0.01% of R.M. Davis Inc's portfolio in Q2 2026, its #244 holding.
- R.M. Davis Inc first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- R.M. Davis Inc's Pfizer position peaked at $18.7M in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on R.M. Davis Inc's 13F filing for Q2 2026, filed 14 Aug 2026.